Short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) decreased during the last reporting period, falling from 13.85M to 13.63M. This put 26.37% of the company's publicly available shares short.

Short interest for ARS Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of ARS Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 891.56K shares traded per day, it would take 15.29 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.